LLY - ELI LILLY & Co
746.06
-9.510 -1.275%
Share volume: 4,422,695
Last Updated: 05-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$755.57
-9.51
-0.01%
View ratios
| Fiscal Date | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 08-08-2023 | 11-02-2023 | 02-19-2025 | 04-30-2024 | 08-08-2024 | 10-30-2024 | 02-19-2025 | 05-01-2025 | |
| Assets | |||||||||
| Total Assets | 54.814 B | 57.916 B | 64.006 B | 63.944 B | 71.875 B | 75.607 B | 78.715 B | 89.389 B | |
| Current Assets | 21.332 B | 23.007 B | 25.727 B | 25.189 B | 30.204 B | 31.415 B | 32.740 B | 41.261 B | |
| Inventories | 4.799 B | 4.901 B | 5.773 B | 6.102 B | 6.482 B | 7.460 B | 7.589 B | 9.311 B | |
| Other Current Assets | 4.532 B | 5.248 B | 149.500 M | 138.600 M | 142.200 M | 134.600 M | 111.400 M | 72.400 M | |
| Short Term Investments | 4.532 B | 5.248 B | 109.100 M | 126.100 M | 140.400 M | 149.400 M | 154.800 M | 127.400 M | |
| Total Receivables | 9.171 B | 10.364 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.829 B | 2.494 B | 2.819 B | 2.460 B | 3.224 B | 3.369 B | 3.268 B | 3.093 B | |
| Total Non-current Assets | 33.482 B | 34.909 B | 3.052 B | 3.087 B | 2.878 B | 3.200 B | 3.216 B | 3.223 B | |
| Property Plant Equipment | 11.277 B | 11.863 B | 12.914 B | 13.624 B | 14.829 B | 16.172 B | 17.102 B | 18.474 B | |
| Other Assets | 4.672 B | 4.912 B | 25.366 B | 25.131 B | 26.841 B | 28.020 B | 28.873 B | 29.654 B | |
| Intangible Assets | 6.904 B | 6.782 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 4.079 B | 4.085 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 54.814 B | 57.916 B | 64.006 B | 63.944 B | 71.875 B | 75.607 B | 78.715 B | 89.389 B | |
| Total liabilities | 43.750 B | 46.695 B | 53.143 B | 51.046 B | 58.239 B | 61.286 B | 64.443 B | 73.542 B | |
| Total current liabilities | 18.915 B | 21.998 B | 27.293 B | 18.598 B | 27.121 B | 24.674 B | 28.377 B | 30.068 B | |
| Accounts Payable | 2.474 B | 2.435 B | 2.599 B | 2.474 B | 2.925 B | 2.887 B | 3.229 B | 3.442 B | |
| Other liabilities | 6.591 B | 6.686 B | 2.241 B | 2.271 B | 2.471 B | 2.239 B | 2.178 B | 2.288 B | |
| Current long term debt | 661.600 M | 2.245 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 18.158 B | 17.924 B | 18.321 B | 24.560 B | 23.730 B | 29.045 B | 28.527 B | 34.500 B | |
| Other liabilities | 6.591 B | 6.686 B | 2.241 B | 2.271 B | 2.471 B | 2.239 B | 2.178 B | 2.288 B | |
| Minority interest | 85.500 M | 87.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 11.064 B | 11.220 B | 10.772 B | 12.812 B | 13.562 B | 14.240 B | 14.192 B | 15.765 B | |
| Common stock | 899.700 M | 899.800 M | 7.844 B | 7.604 B | 7.808 B | 7.934 B | 8.032 B | 7.503 B | |
| Retained earnings | 10.369 B | 10.310 B | 10.312 B | 12.554 B | 13.178 B | 13.627 B | 13.545 B | 15.100 B |
